{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:49:38Z","timestamp":1787964578082,"version":"build-2784847793"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2024-I2M-TS-023"],"award-info":[{"award-number":["2024-I2M-TS-023"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2024-I2M-ZH-015"],"award-info":[{"award-number":["2024-I2M-ZH-015"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-041"],"award-info":[{"award-number":["2021-I2M-1-041"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015406","name":"Tianjin Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["23JCYBJC01050"],"award-info":[{"award-number":["23JCYBJC01050"]}],"id":[{"id":"10.13039\/501100015406","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.exphem.2025.104822","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T02:34:11Z","timestamp":1749263651000},"page":"104822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Advances in RAR\u03b1 fusion genes in acute promyelocytic leukemia"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7551-3906","authenticated-orcid":false,"given":"Ao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3866-0066","authenticated-orcid":false,"given":"Shaowei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2025.104822_bib0001","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/sj.leu.2402718","article-title":"The role of retinoids and retinoic acid receptors in normal hematopoiesis","volume":"16","author":"Collins","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104822_bib0002","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1083\/jcb.200211117","article-title":"Active repression by unliganded retinoid receptors in development: less is sometimes more","volume":"161","author":"Weston","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.exphem.2025.104822_bib0003","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrc1719","article-title":"Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia","volume":"5","author":"Lallemand-Breitenbach","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2025.104822_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2018.06.287","article-title":"Protagonist or antagonist? The complex roles of retinoids in the regulation of hematopoietic stem cells and their specification from pluripotent stem cells","volume":"65","author":"Grace","year":"2018","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2025.104822_bib0005","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3390\/ijms20122921","article-title":"The pleiotropic role of retinoic acid\/retinoic acid receptors signaling: from vitamin A metabolism to gene rearrangements in acute promyelocytic leukemia","volume":"20","author":"Conserva","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.exphem.2025.104822_bib0006","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/ijc.29081","article-title":"Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia","volume":"135","author":"Ablain","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2025.104822_bib0007","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood.2020010100","article-title":"Retinoids in hematology: a timely revival?","volume":"137","author":"Geoffroy","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0008","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/cells12060864","article-title":"Retinoic acid and retinoid X receptors","volume":"12","author":"Schubert","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.exphem.2025.104822_bib0009","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1194\/jlr.R030833","article-title":"Rochette-Egly C. Vitamin A and retinoid signaling: genomic and nongenomic effects","volume":"54","author":"Al Tanoury","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.exphem.2025.104822_bib0010","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood.V98.8.2563","article-title":"Lineage restriction of the RARalpha gene expression in myeloid differentiation","volume":"98","author":"Zhu","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0011","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1182\/blood.V97.5.1314","article-title":"Positive and negative regulation of granulopoiesis by endogenous RARalpha","volume":"97","author":"Kastner","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0012","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exphem.2023.09.008","article-title":"How nutrition regulates hematopoietic stem cell features","volume":"128","author":"Sch\u00f6nberger","year":"2023","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2025.104822_bib0013","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cell.2017.04.018","article-title":"Vitamin A-retinoic acid signaling regulates hematopoietic stem cell dormancy","volume":"169","author":"Cabezas-Wallscheid","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.104822_bib0014","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.stem.2021.10.002","article-title":"Multilayer omics analysis reveals a non-classical retinoic acid signaling axis that regulates hematopoietic stem cell identity","volume":"29","author":"Sch\u00f6nberger","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.104822_bib0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41556-025-01639-4","article-title":"Modulation of bone marrow haematopoietic stem cell activity as a therapeutic strategy after myocardial infarction: a preclinical study","volume":"27","author":"Rettkowski","year":"2025","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2025.104822_bib0016","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.20052105","article-title":"RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation","volume":"203","author":"Purton","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2025.104822_bib0017","first-page":"999","article-title":"RAR\u03b3 is essential for retinoic acid induced chromatin remodeling and transcriptional activation in embryonic stem cells","volume":"126","author":"Kashyap","year":"2013","journal-title":"J Cell Sci"},{"key":"10.1016\/j.exphem.2025.104822_bib0018","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood-2006-04-020552","article-title":"Down-regulation of RXRalpha expression is essential for neutrophil development from granulocyte\/monocyte progenitors","volume":"109","author":"Taschner","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0019","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240519","article-title":"The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes","volume":"221","author":"Esposito","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2025.104822_bib0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood.V89.2.376","article-title":"Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR\u03b1 under control of the cathepsin G regulatory sequences","volume":"89","author":"Grisolano","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0021","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-3-031-62731-6_14","article-title":"Function of PML-RARA in acute promyelocytic leukemia","volume":"1459","author":"Testa","year":"2024","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.exphem.2025.104822_bib0022","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000661","article-title":"PML nuclear bodies","volume":"2","author":"Lallemand-Breitenbach","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.exphem.2025.104822_bib0023","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41418-022-00955-8","article-title":"Deneddylation of PML\/RAR\u03b1 reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL","volume":"29","author":"Shao","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2025.104822_bib0024","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2017-07-794784","article-title":"Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice","volume":"131","author":"Voisset","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0025","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/leu.2011.18","article-title":"The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha","volume":"25","author":"Occhionorelli","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104822_bib0026","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.01.005","article-title":"A sumoylation site in PML\/RARA is essential for leukemic transformation","volume":"7","author":"Zhu","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104822_bib0027","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/jcb.27077","article-title":"PML\/RARa blocks the differentiation and promotes the proliferation of acute promyelocytic leukemia through activating MYB expression by transcriptional and epigenetic regulation mechanisms","volume":"120","author":"Wang","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.exphem.2025.104822_bib0028","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood.2020005698","article-title":"A PML\/RAR\u03b1 direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia","volume":"137","author":"Tan","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0029","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41467-023-36262-0","article-title":"Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia","volume":"14","author":"Villiers","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.104822_bib0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccr.2009.12.045","article-title":"PML\/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia","volume":"17","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104822_bib0031","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/blood-2011-09-378117","article-title":"PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells","volume":"119","author":"Federzoni","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0032","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1189\/jlb.1112608","article-title":"The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C\/EBP\u03b1 during granulocytic differentiation but repressed by PML-RAR\u03b1 in APL","volume":"95","author":"Humbert","year":"2014","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.exphem.2025.104822_bib0033","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.90.20.9345","article-title":"The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1","volume":"90","author":"Doucas","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.exphem.2025.104822_bib0034","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2005-07-3068","article-title":"ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression","volume":"107","author":"Mueller","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0035","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1128\/MCB.20.17.6276-6286.2000","article-title":"Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein","volume":"20","author":"Tsuzuki","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2025.104822_bib0036","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/bloodadvances.2018018929","article-title":"Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia","volume":"2","author":"Gaillard","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2025.104822_bib0037","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/cancers12010095","article-title":"PML\/RARa interferes with NRF2 transcriptional activity increasing the sensitivity to ascorbate of acute promyelocytic leukemia cells","volume":"12","author":"Banella","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2025.104822_bib0038","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13059-020-02030-2","article-title":"Chromatin topology reorganization and transcription repression by PML-RAR\u03b1 in acute promyeloid leukemia","volume":"21","author":"Wang","year":"2020","journal-title":"Genome Biol"},{"key":"10.1016\/j.exphem.2025.104822_bib0039","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccr.2007.06.004","article-title":"RXR is an essential component of the oncogenic PML\/RARA complex in vivo","volume":"12","author":"Zhu","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104822_bib0040","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41401-024-01371-z","article-title":"Palmitoyltransferase ZDHHC3 is essential for the oncogenic activity of PML\/RAR\u03b1 in acute promyelocytic leukemia","volume":"46","author":"Shao","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.exphem.2025.104822_bib0041","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1172\/JCI82897","article-title":"PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia","volume":"126","author":"Cole","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2025.104822_bib0042","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ccell.2017.04.006","article-title":"TRIB3 promotes APL progression through stabilization of the oncoprotein PML-RAR\u03b1 and inhibition of p53-mediated senescence","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104822_bib0043","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41418-023-01139-8","article-title":"Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RAR\u03b1","volume":"30","author":"Dai","year":"2023","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2025.104822_bib0044","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.4161\/auto.29592","article-title":"MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia","volume":"10","author":"Zeng","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.exphem.2025.104822_bib0045","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.apsb.2021.10.020","article-title":"Blockade of deubiquitinase YOD1 degrades oncogenic PML\/RAR\u03b1 and eradicates acute promyelocytic leukemia cells","volume":"12","author":"Shao","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.exphem.2025.104822_bib0046","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2643-3230.BCD-20-0188","article-title":"Hyperthermia selectively destabilizes oncogenic fusion proteins","volume":"2","author":"Maimaitiyiming","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.exphem.2025.104822_bib0047","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","author":"Huang","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0048","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1093\/emboj\/cdg556","article-title":"C\/EBP\u03b2: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells","volume":"22","author":"Duprez","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2025.104822_bib0049","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1073\/pnas.96.26.14807","article-title":"Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor \u03b1 (RAR\u03b1) and oncogenic RAR\u03b1 fusion proteins","volume":"96","author":"Zhu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2025.104822_bib0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/cdd.2016.111","article-title":"The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway","volume":"24","author":"Chen","year":"2017","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2025.104822_bib0051","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12734-4","article-title":"The autophagy scaffold protein ALFY is critical for the granulocytic differentiation of AML cells","volume":"7","author":"Schl\u00e4fli","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2025.104822_bib0052","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1182\/blood-2014-03-561852","article-title":"Clearance of PML\/RARA-bound promoters suffice to initiate APL differentiation","volume":"124","author":"Vitaliano-Prunier","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0053","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nm.3441","article-title":"Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure","volume":"20","author":"Ablain","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2025.104822_bib0054","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJM199105163242002","article-title":"Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)","volume":"324","author":"Warrell","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2025.104822_bib0055","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients","volume":"89","author":"Shen","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0056","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1158\/2159-8290.CD-23-0453","article-title":"Structural basis of PML-RARA oncoprotein targeting by arsenic unravels a cysteine rheostat controlling PML body assembly and function","volume":"13","author":"Bercier","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.exphem.2025.104822_bib0057","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ncb1717","article-title":"Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4\/ubiquitin-mediated pathway","volume":"10","author":"Lallemand-Breitenbach","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2025.104822_bib0058","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ccr.2010.06.003","article-title":"PML\/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3","volume":"18","author":"Jeanne","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104822_bib0059","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2011-10-388496","article-title":"The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML\/RARA through inhibition of PML body recycling","volume":"120","author":"L\u00e5ng","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0060","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ccell.2017.10.002","article-title":"Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure","volume":"32","author":"de Th\u00e9","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104822_bib0061","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/blood.2024026186","article-title":"Acute promyelocytic leukemia: long-term outcomes from the HARMONY project","volume":"145","author":"Voso","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0062","doi-asserted-by":"crossref","first-page":"eaax2746","DOI":"10.1126\/sciadv.aax2746","article-title":"Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation","volume":"6","author":"Ravasio","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.exphem.2025.104822_bib0063","first-page":"370","article-title":"Effects of interferon regulatory factor 9 on the biological phenotypes in PML-RAR\u03b1-induced promyelocytic leukemia]","volume":"43","author":"Yang","year":"2022","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.exphem.2025.104822_bib0064","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm.1891","article-title":"Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation","volume":"14","author":"Nasr","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2025.104822_bib0065","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1084\/jem.20131121","article-title":"Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia","volume":"210","author":"Dos Santos","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2025.104822_bib0066","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2011-01-329433","article-title":"Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment","volume":"118","author":"Goto","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0067","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2015-04-637678","article-title":"Varying responses of PML-RARA with different genetic mutations to arsenic trioxide","volume":"127","author":"Liu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0068","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/cancers11101591","article-title":"Acute promyelocytic leukemia: update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies","volume":"11","author":"Noguera","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2025.104822_bib0069","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2018-07-866095","article-title":"FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias","volume":"133","author":"Esnault","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0070","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1093\/nar\/gky202","article-title":"ZYH005, a novel DNA intercalator, overcomes all-trans retinoic acid resistance in acute promyelocytic leukemia","volume":"46","author":"Tong","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2025.104822_bib0071","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.arcmed.2020.06.002","article-title":"c-Myc inhibition using 10058-F4 increased the sensitivity of acute promyelocytic leukemia cells to arsenic trioxide via blunting PI3K\/NF-\u03baB axis","volume":"51","author":"Sayyadi","year":"2020","journal-title":"Arch Med Res"},{"key":"10.1016\/j.exphem.2025.104822_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115675","article-title":"The clinically relevant CHK1 inhibitor MK-8776 induces the degradation of the oncogenic protein PML-RAR\u03b1 and overcomes ATRA resistance in acute promyelocytic leukemia cells","volume":"214","author":"Franza","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.exphem.2025.104822_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115314","article-title":"Targeting DHODH reveals therapeutic opportunities in ATRA-resistant acute promyelocytic leukemia","volume":"166","author":"Yang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.exphem.2025.104822_bib0074","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V85.4.1083.bloodjournal8541083","article-title":"Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)","volume":"85","author":"Licht","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0075","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.leu.2403645","article-title":"Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia","volume":"19","author":"Nicci","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104822_bib0076","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ng0997-109","article-title":"Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia","volume":"17","author":"Wells","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2025.104822_bib0077","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/hmg\/8.9.1741","article-title":"The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia","volume":"8","author":"Arnould","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.exphem.2025.104822_bib0078","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/leu.2012.371","article-title":"All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene","volume":"27","author":"Strehl","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104822_bib0079","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1182\/blood-2007-06-095554","article-title":"The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia","volume":"110","author":"Catalano","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0080","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3324\/haematol.12854","article-title":"The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia","volume":"93","author":"Kondo","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.104822_bib0081","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2010-01-264432","article-title":"BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia","volume":"116","author":"Yamamoto","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0082","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cancergen.2015.01.008","article-title":"Successful treatment of acute promyelocytic leukemia with a t(X;17)(p11.4;q21) and BCOR-RARA fusion gene","volume":"208","author":"Ichikawa","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.exphem.2025.104822_bib0083","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1182\/blood-2012-04-423129","article-title":"OBFC2A\/RARA: a novel fusion gene in variant acute promyelocytic leukemia","volume":"121","author":"Won","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0084","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood-2013-10-528596","article-title":"TBLR1 fuses to retinoid acid receptor \u03b1 in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia","volume":"124","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0085","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/bjh.13157","article-title":"GTF2I-RARA is a novel fusion transcript in a t(7;17) variant of acute promyelocytic leukaemia with clinical resistance to retinoic acid","volume":"168","author":"Li","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2025.104822_bib0086","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6004\/jnccn.2015.0005","article-title":"Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia","volume":"13","author":"Yin","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.exphem.2025.104822_bib0087","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1080\/10428194.2017.1421761","article-title":"IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid","volume":"59","author":"Mazharuddin","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2025.104822_bib0088","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1182\/blood-2017-02-767707","article-title":"FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia","volume":"129","author":"Cheng","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0089","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2017-09-807370","article-title":"Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t(15;17)(q22;q12)\/PML-RARA","volume":"131","author":"Yao","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.leukres.2018.09.012","article-title":"TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid","volume":"74","author":"Chong","year":"2018","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2025.104822_bib0091","doi-asserted-by":"crossref","first-page":"E184","DOI":"10.1002\/ajh.25807","article-title":"Identification of a novel NUP98-RARA fusion transcript as the 14th variant of acute promyelocytic leukemia","volume":"95","author":"Zhu","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2025.104822_bib0092","doi-asserted-by":"crossref","DOI":"10.1002\/mc.23276","article-title":"Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)\/PML-RARA","volume":"60","author":"Wang","year":"2021","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.exphem.2025.104822_bib0093","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1111\/bjh.17642","article-title":"A novel HNRNPC-RARA fusion in acute promyelocytic leukaemia lacking PML-RARA rearrangement, sensitive to venetoclax-based therapy","volume":"195","author":"Liu","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2025.104822_bib0094","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/blood.2021011677","article-title":"Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML\/RARA fusion","volume":"138","author":"Astolfi","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0095","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1182\/bloodadvances.2022007256","article-title":"TTMV-RARA fusion as arecurrent cause of AML with APL characteristics","volume":"6","author":"Sala-Torra","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2025.104822_bib0096","article-title":"Clinical response to venetoclax and decitabine in acute promyelocytic leukemia with a novel RARA-THRAP3 fusion: a case report","volume":"12","author":"Song","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.exphem.2025.104822_bib0097","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/bjh.18907","article-title":"Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity","volume":"202","author":"Ng","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2025.104822_bib0098","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1182\/blood.2023020619","article-title":"Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia","volume":"142","author":"Zhang","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0099","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/ajh.27272","article-title":"Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia","volume":"99","author":"Jiang","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2025.104822_bib0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1028089","article-title":"Case report: A rare case of TBL1XR1-RARB positive acute promyelocytic leukemia in child and review of the literature","volume":"12","author":"Jiang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.exphem.2025.104822_bib0101","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/gcc.23180","article-title":"Clinical and genomic characterization of an ATRA-insensitive acute promyelocytic leukemia variant with a FNDC3B::RARB fusion","volume":"62","author":"Kirkham","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2025.104822_bib0102","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1007\/s00277-024-05833-6","article-title":"A HNRNPC::RARB variant of acute promyelocytic leukemia with concurrent myeloid sarcoma of the spine","volume":"103","author":"Li","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2025.104822_bib0103","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood-2010-06-291658","article-title":"A novel NUP98\/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia","volume":"117","author":"Such","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104822_bib0104","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1038\/leu.2017.167","article-title":"Identification of a novel PML-RARG fusion in acute promyelocytic leukemia","volume":"31","author":"Ha","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104822_bib0105","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1002\/ajh.25689","article-title":"Acute myeloid leukemia with a novel CPSF6-RARG variant is sensitive to homoharringtonine and cytarabine chemotherapy","volume":"95","author":"Zhang","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2025.104822_bib0106","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.3324\/haematol.2019.244715","article-title":"Novel reciprocal fusion genes involving HNRNPC and RARG in acute promyelocytic leukemia lacking RARA rearrangement","volume":"105","author":"Su","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.104822_bib0107","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41416-019-0456-z","article-title":"A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide","volume":"120","author":"Chen","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.exphem.2025.104822_bib0108","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/16078454.2022.2066825","article-title":"A short report of novel RARG-HNRNPM fusion gene in resembling acute promyelocytic leukemia","volume":"27","author":"Song","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.exphem.2025.104822_bib0109","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3324\/haematol.2022.281766","article-title":"A novel SART3::RARG fusion gene in acute myeloid leukemia with acute promyelocytic leukemia phenotype and differentiation escape to retinoic acid","volume":"108","author":"Li","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.104822_bib0110","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/hon.3170","article-title":"Report of PRPF19 as a novel partner of RARG and the recurrence of interposition-type fusion in variant acute promyelocytic leukemia","volume":"41","author":"Wu","year":"2023","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.exphem.2025.104822_bib0111","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.seminoncol.2019.04.004","article-title":"Acute promyelocytic leukemia and variant fusion proteins: PLZF-RAR\u03b1 fusion protein at a glance","volume":"46","author":"Hussain","year":"2019","journal-title":"Semin Oncol"},{"key":"10.1016\/j.exphem.2025.104822_bib0112","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41408-021-00561-w","article-title":"Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants","volume":"11","author":"Cicconi","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.exphem.2025.104822_bib0113","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41419-021-03889-0","article-title":"A novel fusion protein TBLR1-RAR\u03b1 acts as an oncogene to induce murine promyelocytic leukemia: identification and treatment strategies","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.exphem.2025.104822_bib0114","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.2024024008","article-title":"DiNardo CD. How I treat acute myeloid leukemia with differentiation therapy","volume":"145","author":"Issa","year":"2025","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25001134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25001134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:33:51Z","timestamp":1755617631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X25001134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":114,"alternative-id":["S0301472X25001134"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104822","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in RAR\u03b1 fusion genes in acute promyelocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104822"}}